A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants with Myelofibrosis

Principal investigator: Minna Lehto
HUS, Helsinki University Hospital, Comprehensive Cancer Center

Link to the ClinicalTrials.gov study website